Regulatory review details risk management frameworks under amended chemical control legislation, highlighting enhanced oversight of hazardous industrial substances.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Shigeki NOGUCHI (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: